Shell Asset Management Co. raised its holdings in Thermo Fisher Scientific Inc (NYSE:TMO) by 164.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 81,451 shares of the medical research company’s stock after purchasing an additional 50,684 shares during the period. Shell Asset Management Co.’s holdings in Thermo Fisher Scientific were worth $9,913,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in the business. Proficio Capital Partners LLC increased its position in Thermo Fisher Scientific by 71.5% during the first quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock worth $105,000 after purchasing an additional 253 shares during the last quarter. Cribstone Capital Management LLC increased its position in Thermo Fisher Scientific by 8.7% during the second quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock worth $109,000 after purchasing an additional 50 shares during the last quarter. Shine Investment Advisory Services Inc. acquired a new position in Thermo Fisher Scientific during the second quarter worth approximately $113,000. Chicago Partners Investment Group LLC acquired a new position in Thermo Fisher Scientific during the second quarter worth approximately $108,000. Finally, CWM LLC increased its position in Thermo Fisher Scientific by 17.0% during the second quarter. CWM LLC now owns 710 shares of the medical research company’s stock worth $124,000 after purchasing an additional 103 shares during the last quarter. 83.78% of the stock is currently owned by institutional investors.
Several equities analysts recently commented on TMO shares. Barclays PLC reaffirmed an “overweight” rating and set a $200.00 price target (up previously from $190.00) on shares of Thermo Fisher Scientific in a research report on Monday, July 17th. Cleveland Research raised shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research report on Thursday, July 20th. Bank of America Corporation reaffirmed a “buy” rating and set a $210.00 price target (up previously from $200.00) on shares of Thermo Fisher Scientific in a research report on Friday, July 21st. Zacks Investment Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Finally, BidaskClub lowered shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. One equities research analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $205.71.
In related news, VP Peter E. Hornstra sold 3,894 shares of the firm’s stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $185.18, for a total transaction of $721,090.92. Following the completion of the sale, the vice president now directly owns 19,751 shares of the company’s stock, valued at approximately $3,657,490.18. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Seth H. Hoogasian sold 4,140 shares of the firm’s stock in a transaction on Monday, August 28th. The shares were sold at an average price of $177.80, for a total transaction of $736,092.00. Following the sale, the vice president now directly owns 25,518 shares of the company’s stock, valued at $4,537,100.40. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 22,738 shares of company stock valued at $4,021,512. Company insiders own 0.49% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://ledgergazette.com/2017/11/13/shell-asset-management-co-acquires-50684-shares-of-thermo-fisher-scientific-inc-tmo.html.
Shares of Thermo Fisher Scientific Inc (NYSE:TMO) opened at $186.18 on Monday. The firm has a market cap of $74,657.32, a price-to-earnings ratio of 20.46, a P/E/G ratio of 1.71 and a beta of 1.08. Thermo Fisher Scientific Inc has a fifty-two week low of $139.07 and a fifty-two week high of $201.20. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.85.
Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.24 by $0.07. The business had revenue of $5.12 billion during the quarter, compared to analyst estimates of $5.03 billion. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The business’s revenue was up 13.9% on a year-over-year basis. During the same period last year, the business earned $2.03 EPS. equities analysts anticipate that Thermo Fisher Scientific Inc will post 9.36 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Friday, December 15th will be issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date of this dividend is Thursday, December 14th. Thermo Fisher Scientific’s payout ratio is 10.19%.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.